Clearmind Medicine (Clearmind Medicine) Operating Cash Flow per Share : $-2.00 (TTM As of Apr. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Operating Cash Flow per Share?

Clearmind Medicine's operating cash flow per share for the three months ended in Apr. 2024 was $-0.37. Clearmind Medicine's operating cash flow per share for the trailing twelve months (TTM) ended in Apr. 2024 was $-2.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -26.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -55.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Clearmind Medicine's Operating Cash Flow per Share or its related term are showing as below:

CMND' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -151.5 Med: -95.2 Max: -26.8
Current: -26.8

During the past 7 years, Clearmind Medicine's highest 3-Year average Operating Cash Flow per Share Growth Rate was -26.80% per year. The lowest was -151.50% per year. And the median was -95.20% per year.

CMND's 3-Year OCF Growth Rate is ranked worse than
79.19% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs CMND: -26.80

Clearmind Medicine Operating Cash Flow per Share Historical Data

The historical data trend for Clearmind Medicine's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Operating Cash Flow per Share Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-4.00

-11.06

-54.07

-63.65

-22.56

Clearmind Medicine Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-8.55	-0.06	-0.61	-0.96	-0.37

Competitive Comparison of Clearmind Medicine's Operating Cash Flow per Share

For the Biotechnology subindustry, Clearmind Medicine's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearmind Medicine's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Price-to-Operating-Cash-Flow falls into.

Clearmind Medicine Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Clearmind Medicine's Operating Cash Flow per Share for the fiscal year that ended in Oct. 2023 is calculated as

Operating Cash Flow per Share (A: Oct. 2023 )	=	Cash Flow from Operations (A: Oct. 2023 )	/	Shares Outstanding (Diluted Average) (A: Oct. 2023 )
	=	-4.557	/	0.202
	=	-22.56

Clearmind Medicine's Operating Cash Flow per Share for the quarter that ended in Oct. 2023 is calculated as

Operating Cash Flow per Share (Q: Apr. 2024 )	=	Cash Flow from Operations (Q: Apr. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Apr. 2024 )
	=	-1.193	/	3.253
	=	-0.37

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.00

Clearmind Medicine Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.